Fig. 7.
![Fig. 7. Ca2+ responses to specific PAR-2 and TR agonists. Indo-1–loaded cells were stimulated with either the PAR-2–specific agonist SLIGKV (120 μmol/L; solid line) or the TR-specific agonist TFRIFD (120 μmol/L; dotted line), and intracellular [Ca2+] was measured using a spectrofluorimeter. (A) MEG-01; (B) Jurkat; (C) J.RT-T3.5 (TCR-negative); and (D) J.CaM1/rep3 (lck-deficient).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/5/10.1182_blood.v90.5.1893/4/bl_0018f7.jpeg?Expires=1724234919&Signature=n63S-w3BjnVKdQH0-YwKUnCp~87JwWCEo-qBBZscS3ga6QTrlMNxA3pGmhRD5ojxtWFaNxUZ3eJwPnY0rVu~ppFPyBV8x5XFfhA8yS2vDVYDzPAZkHtdsa224itIv86QIfQi6goZ2rEnz~ZamLNxJaSzAk2mD~3RdgVy9Vajn~RbEbLUzwlpyMwW7hNPSoHo-TFKeDK4DLOWdksNC5ieoMmx9Uqg1tG2QIZR9FFbFOBBd3S8wCOUkfrU-A0TLWwcb5B57fjtik~WFKsxCuYVS6Q3GcVW~GXGAXEVNHE6j~1c2JP3t5OEAXctIvc8OXupeZLcg4z1MyDuNjls~qPi2w__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Ca2+ responses to specific PAR-2 and TR agonists. Indo-1–loaded cells were stimulated with either the PAR-2–specific agonist SLIGKV (120 μmol/L; solid line) or the TR-specific agonist TFRIFD (120 μmol/L; dotted line), and intracellular [Ca2+] was measured using a spectrofluorimeter. (A) MEG-01; (B) Jurkat; (C) J.RT-T3.5 (TCR-negative); and (D) J.CaM1/rep3 (lck-deficient).
